-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
Acetyl-pepstatin
![{PARAM:[Name]}({[CAS]})](https://resource.bocsci.com/structure/acetyl-pepstatin.gif)
| Category | Human immunodeficiency Virus (HIV) |
| Description | Acetyl-pepstatin is a potent classical inhibitor of aspartic proteases (PRs) with XMRV PR and HIV-1 PR Ki values of 712 nM and 13 nM. |
Product Information
| Synonyms | Acetyl-pepstatin|Acetylpepstatin|Acetyl pepstatin|28575-34-0|Ac-Val-Val-Sta-Ala-Sta|(3S,4S)-4-[[(2S)-2-[[(3S,4S)-4-[[(2S)-2-[[(2S)-2-acetamido-3-methylbutanoyl]amino]-3-methylbutanoyl]amino]-3-hydroxy-6-methylheptanoyl]amino]propanoyl]amino]-3-hydroxy-6-methylheptanoic acid|Pepstatin Ac|Pepsidin C|Pepsidine C|5hvp|N-Acetyl Pepstatin|S-PI|S-PI (pepsin inhibitor)|CHEMBL301728|SCHEMBL10777706|DTXSID70182781|Pepsin inhibitor S-PI-D (8CI)|HY-P1436|BDBM50368642|MFCD00214071|ZINC29473291|AKOS027470304|Pepstatin A, 1-(N-acetyl-L-valine)-|(3S,4S)-4-[[(2S)-2-[[(3S,4S)-4-[[(2S)-2-[[(2S)-2-acetamido-3-methyl-butanoyl]amino]-3-methyl-butanoyl]amino]-3-hydroxy-6-methyl-heptanoyl]amino]propanoyl]amino]-3-hydroxy-6-methyl-heptanoic acid|Pepsin inhibitor (Streptomyces naniwaensis)|CS-0033333|J-017129|(3S,7S,11S,12S,14S,18S)-11-Acetoxy-14-carbamoyl-3-hydroxy-4,12-diisobutyl-18-isopropyl-7,15,22-trimethyl-6,9,17,20-tetraoxo-5,8,13,19-tetraazatricosan-1-oic acid|L-Alaninamide, N-acetyl-L-valyl-L-valyl-(3S,4S)-4-amino-3-hydroxy-6-methylheptanoyl-N-[(1S)-1-[(1S)-2-carboxy-1-hydroxyethyl]-3-methylbutyl]- (9CI)|L-valinamide, N-acetyl-L-valyl-N-[(1S,2S)-4-[[(1S)-2-[[(1S)-1-[(1S)-2-carboxy-1-hydroxyethyl]-3-methylbutyl]amino]-1-methyl-2-oxoethyl]amino]-2-hydroxy-1-(2-methylpropyl)-4-oxobutyl]- |
| Molecular Weight | 643.812 |
| Molecular Formula | C31H57N5O9 |
| Canonical SMILES | CC(C)CC(C(CC(=O)O)O)NC(=O)C(C)NC(=O)CC(C(CC(C)C)NC(=O)C(C(C)C)NC(=O)C(C(C)C)NC(=O)C)O |
| Boiling Point | 992.8±65.0 °C at 760 mmHg |
| Flash Point | 554.2±34.3 °C |
| Purity | ≥98% (HPLC) |
| Density | 1.1±0.1 g/cm3 |
| Solubility | In Vitro: H2O |
| Appearance | Solid powder |
| Storage | Store at -20°C |
| Complexity | 1000 |
| Exact Mass | 643.415649 |
| Index Of Refraction | 1.508 |
| PSA | 223.26000 |
| Target | Ki: 13 nM (XMRV PR) and 712 nM (XMRV PR)HIV |
| Vapor Pressure | 0.0±0.6 mmHg at 25°C |
| XLogP3-AA | 1.7 |